Blood pressure in children and adolescents with congenital adrenal hyperplasia (21-hydroxylase deficiency): a preliminary report
- PMID: 12699440
- DOI: 10.1046/j.1365-2265.2003.01757.x
Blood pressure in children and adolescents with congenital adrenal hyperplasia (21-hydroxylase deficiency): a preliminary report
Abstract
Background: Classical congenital adrenal hyperplasia (CAH) is characterized by a defect in cortisol and aldosterone secretion, adrenal hyperandrogenism, impaired adrenal medullary function and insulin insensitivity. The latter along with the increased tendency towards obesity raises questions whether other cardiovascular risk factors are altered in CAH.
Objective: To evaluate 24-h ambulatory blood pressure and obesity in patients with salt-wasting 21-hydroxylase deficiency diagnosed in the neonatal period and treated with hydrocortisone and 9alpha-fludrocortisone thereafter.
Methods: Thirty-eight children (15 males) aged 11.2 years (range 6.1-18.2 years) underwent 24-h ambulatory blood pressure monitoring in the hospital setting. Standard anthropometric measures of height, weight and skinfold thickness were undertaken and body mass index (BMI) derived. All data were expressed as standard deviation scores (SDS) using the UK Growth Reference data.
Results: Mean daytime systolic blood pressure SDS (1.8, SD 1.1) was significantly higher than the reference population (P < 0.001), and 58% of patients (67% males; 52% females) had systolic hypertension. Mean daytime diastolic blood pressure SDS (0.8, SD 0.8) was also elevated and 24% (13% males; 37% females) had diastolic hypertension. Eighty-four per cent had absence of the physiological nocturnal dip in systolic blood pressure. Height SDS was similar to the reference population but BMI SDS was higher (P < 0.001). BMI SDS was related to systolic blood pressure SDS (r = 0.34; P = 0.03) and the effect was most marked in females where it was related to measures of truncal fat (r = 0.82; P = 0.002).
Conclusions: Children with salt-wasting 21-hydroxylase deficiency have elevated 24-h ambulatory blood pressure and absence of the physiological nocturnal dip in blood pressure. These abnormalities are associated with a raised BMI, particularly in females. Regular measurement and plotting of blood pressure should be part of the management of children with classical CAH.
Similar articles
-
Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.Pediatrics. 2006 Jan;117(1):e98-105. doi: 10.1542/peds.2005-1005. Pediatrics. 2006. PMID: 16396852
-
Altered 24-hour blood pressure profiles in children and adolescents with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency.J Clin Endocrinol Metab. 2006 Dec;91(12):4888-95. doi: 10.1210/jc.2006-1069. Epub 2006 Sep 26. J Clin Endocrinol Metab. 2006. PMID: 17003094
-
Blood Pressure in a Large Cohort of Children and Adolescents With Classic Adrenal Hyperplasia (CAH) Due to 21-Hydroxylase Deficiency.Am J Hypertens. 2016 Feb;29(2):266-72. doi: 10.1093/ajh/hpv087. Epub 2015 Jun 11. Am J Hypertens. 2016. PMID: 26071487
-
Long-term prednisone versus hydrocortisone treatment in children with classic Congenital Adrenal Hyperplasia (CAH) and a brief review of the literature.Acta Biomed. 2019 Sep 6;90(3):360-369. doi: 10.23750/abm.v90i3.8732. Acta Biomed. 2019. PMID: 31580328 Free PMC article. Review.
-
Growth patterns and final height in congenital adrenal hyperplasia due to classical 21-hydroxylase deficiency. Results of a multicenter study.Horm Res. 2001;55(4):161-71. doi: 10.1159/000049990. Horm Res. 2001. PMID: 11598369 Review.
Cited by
-
Blood Pressure and Left Ventricular Characteristics in Young Patients with Classical Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency.Int J Pediatr Endocrinol. 2009;2009:383610. doi: 10.1155/2009/383610. Epub 2010 Feb 7. Int J Pediatr Endocrinol. 2009. PMID: 20169124 Free PMC article.
-
Growth and reproductive outcomes in congenital adrenal hyperplasia.Int J Pediatr Endocrinol. 2010;2010:298937. doi: 10.1155/2010/298937. Epub 2010 Feb 1. Int J Pediatr Endocrinol. 2010. PMID: 20148087 Free PMC article.
-
Cardiovascular Health in Children and Adolescents With Congenital Adrenal Hyperplasia Due to 21-Hydroxilase Deficiency.Front Endocrinol (Lausanne). 2019 Apr 11;10:212. doi: 10.3389/fendo.2019.00212. eCollection 2019. Front Endocrinol (Lausanne). 2019. PMID: 31031703 Free PMC article. Review.
-
Optimizing the Timing of Highest Hydrocortisone Dose in Children and Adolescents With 21-Hydroxylase Deficiency.J Clin Endocrinol Metab. 2022 Mar 24;107(4):e1661-e1672. doi: 10.1210/clinem/dgab826. J Clin Endocrinol Metab. 2022. PMID: 34788830 Free PMC article.
-
Treatment and health outcomes in adults with congenital adrenal hyperplasia.Nat Rev Endocrinol. 2014 Feb;10(2):115-24. doi: 10.1038/nrendo.2013.239. Epub 2013 Dec 17. Nat Rev Endocrinol. 2014. PMID: 24342885 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical